Written and medically reviewed by Kwaku Osafo-Mensah, MD
Pulmonary Medicine | Sleep Medicine | Diplomate, American Board of Sleep Medicine (ABSM)
Medically reviewed: September 2026.

Why Do Untreated Sleep Apnea Risks Matter?

Obstructive sleep apnea is more than snoring.

During untreated obstructive sleep apnea, the upper airway repeatedly narrows or closes during sleep. Breathing may decrease substantially or stop temporarily, even though the body continues trying to breathe.

This cycle may occur dozens—or in severe cases, hundreds—of times during a night.

Each episode can produce a combination of:

• Reduced airflow
• Falling oxygen levels
• Changes in carbon dioxide
• Increasing respiratory effort
• Large changes in intrathoracic pressure
• Brief arousal from sleep
• Reopening of the airway
• Increased heart rate and blood pressure
• Fragmentation of normal sleep

The person may remember little or nothing about these events the next morning.

Yet throughout the night, untreated sleep apnea may have repeatedly stressed the cardiovascular and nervous systems.

That is why untreated sleep apnea risks extend beyond simply feeling tired.

Quick Answer: What Are the Major Risks of Untreated Sleep Apnea?

Untreated obstructive sleep apnea is associated with increased risk or greater prevalence of several important health and safety problems, including:

• High blood pressure
• Resistant hypertension
• Cardiovascular disease
• Atrial fibrillation and other arrhythmias
• Stroke
• Heart failure
• Excessive daytime sleepiness
• Impaired attention and vigilance
• Motor-vehicle crashes
• Occupational accidents
• Perioperative and postoperative respiratory complications
• Metabolic dysfunction
• Reduced quality of life

However, an important distinction is necessary:

An association between OSA and a disease does not mean that sleep apnea is the only cause of that disease—or that treating OSA completely eliminates the risk.

Cardiovascular and cerebrovascular disease are multifactorial.

Age, genetics, obesity, smoking, diabetes, cholesterol, kidney disease, physical activity, medications, alcohol, and many other factors may contribute.

OSA should therefore be considered one potentially important component of overall risk. For a broader overview of obstructive sleep apnea—including symptoms, risk factors, diagnosis, testing, and treatment options—see Sleep Apnea: Symptoms, Testing, Treatment & What You Need to Know.

What Happens to the Body During an Obstructive Apnea?

Consider a simplified sequence.

Step 1: The Upper Airway Narrows or Closes

During sleep, upper-airway muscle tone decreases.

In a susceptible person, the pharyngeal airway becomes unstable.

Airflow decreases substantially or stops.

Step 2: Breathing Effort Continues

In obstructive sleep apnea, the brain generally continues sending signals to breathe.

The diaphragm and chest wall attempt to move air against the obstructed airway.

This distinguishes an obstructive event from a central apnea, in which respiratory effort may be absent.

For more about how obstructive and central respiratory events differ, see Central vs. Obstructive Sleep Apnea: What’s the Difference?

Step 3: Oxygen May Fall

If airflow remains reduced long enough, oxygen saturation may decline.

The magnitude of desaturation varies according to:

• Event duration
• Baseline oxygenation
• OSA severity
• Lung disease
• Obesity
• Sleeping position
• Sleep stage
• Individual physiology

Not every apnea produces the same oxygen response.

For a detailed explanation of oxygen desaturation during OSA, see Sleep Apnea and Oxygen Levels: How Low Is Too Low?

Step 4: Carbon Dioxide May Rise

Reduced ventilation can allow carbon dioxide to increase during an obstructive event.

In uncomplicated OSA, ventilation usually increases again when the airway reopens.

Persistent sleep-related hypoventilation is a different clinical problem and deserves separate evaluation.

Step 5: Respiratory Effort Increases

The patient attempts to breathe against a narrowed or closed upper airway.

This can generate substantial negative intrathoracic pressure.

Those pressure swings may affect:

• Cardiac loading conditions
• Venous return
• Ventricular wall stress
• Atrial mechanics

These effects occur repeatedly when obstructive events recur throughout the night.

Step 6: The Brain Arouses

Eventually the obstruction may terminate with a brief arousal.

Upper-airway muscle activity increases.

The airway reopens.

Breathing resumes.

The patient may not consciously remember waking.

Step 7: Sympathetic Activity Increases

The combination of:

• Obstruction
• Hypoxemia
• Hypercapnia when present
• Arousal
• Respiratory effort

can activate the sympathetic nervous system.

Heart rate and blood pressure may rise.

Step 8: The Patient Falls Back Asleep

Then the airway may narrow again.

The cycle repeats.

In significant untreated OSA, this can happen repeatedly throughout the night.

Why Is Repetition Important?

One obstructive event is not the same as years of repetitive sleep-disordered breathing.

OSA can expose the body night after night to:

obstruction → oxygen disturbance → respiratory effort → arousal → sympathetic activation → recovery

followed by another cycle.

Potential physiologic consequences include:

• Intermittent hypoxemia
• Recurrent blood-pressure surges
• Sympathetic activation
• Sleep fragmentation
• Oxidative stress
• Inflammatory signaling
• Endothelial dysfunction
• Metabolic dysregulation

These mechanisms help explain why OSA has been studied extensively in relation to cardiovascular and cerebrovascular disease.

Does AHI Tell You the Entire Health Risk?

No.

AHI is important, but it is not a complete cardiovascular-risk measurement.

Two patients can both have:

AHI = 25 events/hour

yet have very different physiologic exposure.

For example, one may have:

• Short respiratory events
• Mild oxygen changes
• Little daytime sleepiness

while another has:

• Longer events
• Repeated substantial desaturation
• Marked sleep fragmentation
• Hypertension
• Significant daytime sleepiness

AHI alone does not capture all of those differences.

For more about what AHI measures—and what it does not—see AHI Explained: What Your Apnea-Hypopnea Index Means.

What Is Hypoxic Burden?

Researchers increasingly examine not only how many respiratory events occur, but also the magnitude and duration of oxygen disturbances associated with those events.

This broader concept is sometimes described using measures such as hypoxic burden.

Conceptually:

AHI asks how frequently respiratory events occur.

Hypoxic-burden approaches attempt to characterize more of the oxygen-related physiologic burden associated with those events.

This does not mean AHI is obsolete.

It means OSA severity and cardiovascular risk may be more complex than a single event-frequency number.

Does Untreated Sleep Apnea Cause High Blood Pressure?

OSA is strongly associated with hypertension, and there are biologically plausible mechanisms linking the two.

But hypertension is usually multifactorial.

It would therefore be overly simplistic to say:

“Sleep apnea is the cause of your high blood pressure.”

A more accurate statement is:

Obstructive sleep apnea can contribute to blood-pressure dysregulation and is an important potentially modifiable factor in appropriate patients with hypertension.

How Can Sleep Apnea Raise Blood Pressure?

Several mechanisms may contribute.

Sympathetic Nervous-System Activation

Repeated obstructive events and arousals can produce sympathetic surges.

Blood pressure may rise during and immediately after respiratory events.

With repeated exposure, sympathetic activation may extend beyond sleep.

Intermittent Hypoxemia

Repeated oxygen reductions may contribute to vascular and autonomic changes.

Sleep Fragmentation

Repeated arousals disrupt normal sleep architecture and may contribute to neurohumoral stress.

Endothelial and Vascular Effects

OSA has been associated with endothelial dysfunction, oxidative stress, and inflammatory pathways that may influence vascular regulation.

Intrathoracic Pressure Changes

Repeated attempts to breathe against an obstructed airway produce substantial pressure changes within the chest that may affect cardiovascular loading.

The relationship is therefore more complex than simply:

low oxygen → high blood pressure.

What Is Nocturnal Hypertension?

Blood pressure normally follows a circadian pattern.

For many people, blood pressure decreases during sleep compared with daytime levels.

This is often referred to as nocturnal dipping.

Some patients with OSA may have:

• Elevated nighttime blood pressure
• Reduced nocturnal dipping
• A nondipping pattern
• Recurrent blood-pressure surges associated with respiratory events

These patterns may be clinically important even when an office blood-pressure reading does not tell the entire story.

What Is Resistant Hypertension?

Resistant hypertension generally refers to blood pressure that remains above goal despite an appropriate multidrug treatment strategy, after issues such as adherence and measurement are considered.

OSA is common among patients with resistant hypertension.

Therefore, when clinically appropriate, sleep apnea may be considered as part of the evaluation of difficult-to-control blood pressure.

But finding OSA does not mean:

“Stop the blood-pressure medications and use CPAP instead.”

These treatments address different aspects of cardiovascular risk.

Does CPAP Lower Blood Pressure?

PAP treatment can lower blood pressure in some patients with OSA, but the average effect in clinical studies is generally modest rather than dramatic.

The response varies.

Potential determinants include:

• Baseline blood pressure
• OSA severity
• Daytime sleepiness
• PAP adherence
• Hours of PAP use
• Resistant hypertension
• Individual physiology

Some patients may experience a clinically meaningful improvement.

Others may have little measurable change.

Should Blood-Pressure Medication Be Stopped After Starting CPAP?

Not simply because PAP has been started.

Blood-pressure therapy should be adjusted according to actual blood-pressure measurements and the patient’s overall clinical circumstances.

PAP treatment and antihypertensive therapy are often complementary rather than competing treatments.

Can You Have High Blood Pressure Without Sleep Apnea?

Absolutely.

Hypertension has many causes and risk factors.

Likewise, a person can have significant OSA without diagnosed hypertension.

The presence or absence of one condition does not establish the presence or absence of the other.

Does Treating Sleep Apnea Guarantee Normal Blood Pressure?

No.

Even highly effective PAP therapy does not eliminate:

• Genetic risk
• Obesity
• Kidney disease
• High sodium intake
• Vascular disease
• Endocrine causes
• Medication effects
• Other contributors to hypertension

OSA treatment should therefore be considered part of comprehensive cardiovascular risk management.

Why Is Resistant Hypertension Particularly Important?

When blood pressure remains difficult to control, identifying potentially contributing conditions becomes increasingly important.

OSA is one such condition.

The clinically useful question is not:

“Is OSA the only reason the blood pressure is high?”

It is:

“Could untreated OSA be contributing to a blood-pressure problem that already has multiple causes?”

That is a much more realistic framework.

Does Sleep Apnea Increase Cardiovascular Risk?

OSA is associated with cardiovascular disease in observational research, particularly when disease is moderate to severe or accompanied by important physiologic consequences.

Potential cardiovascular associations include:

• Hypertension
• Coronary artery disease
• Atrial fibrillation
• Other arrhythmias
• Heart failure
• Stroke
• Cardiovascular morbidity and mortality

However, the relationship is complicated by shared risk factors.

For example, obesity increases the risk of both:

OSA

and:

cardiovascular disease.

Therefore, careful studies attempt to account for these overlapping factors.

Does Association Mean Causation?

No.

This is particularly important when discussing untreated sleep apnea risks.

If patients with OSA have more cardiovascular disease, several explanations may contribute:

1. OSA itself may contribute biologically.
2. OSA and cardiovascular disease may share risk factors.
3. Both mechanisms may be present.
4. The effect may differ among OSA phenotypes and patient populations.

That is why high-quality medical interpretation should avoid saying:

“OSA causes every cardiovascular event.”

But it would also be inaccurate to dismiss the cardiovascular relationship entirely.

Why Might OSA Affect the Heart?

Potential mechanisms include:

• Intermittent hypoxemia
• Sympathetic activation
• Recurrent blood-pressure surges
• Oxidative stress
• Inflammatory pathways
• Endothelial dysfunction
• Intrathoracic pressure changes
• Sleep fragmentation
• Metabolic dysfunction

These mechanisms can interact with existing cardiovascular disease.

Does Treating OSA Prevent Heart Attacks?

This requires nuance.

PAP effectively treats obstructive respiratory events while it is being used appropriately.

It can improve important outcomes such as sleepiness and sleep-related breathing.

However, randomized cardiovascular-outcome trials have not established that prescribing PAP guarantees prevention of myocardial infarction, stroke, or every major cardiovascular event in all populations with OSA.

Several factors complicate those studies, including:

• Patient selection
• Baseline sleepiness
• PAP adherence
• Hours of nightly treatment
• Established cardiovascular disease
• OSA phenotype

Therefore, we should not promise:

“Use CPAP and you won’t have a heart attack.”

The appropriate message is:

Treat OSA effectively while also addressing the patient’s other cardiovascular risk factors.

What Other Cardiovascular Risks Still Need Treatment?

Depending on the individual:

• Hypertension
• Diabetes
• Dyslipidemia
• Smoking
• Obesity
• Physical inactivity
• Atrial fibrillation
• Coronary disease
• Kidney disease
• Diet
• Alcohol use

OSA treatment should fit within broader cardiovascular prevention rather than replace it.

Sleep Apnea and Atrial Fibrillation

Atrial fibrillation, often abbreviated AF or AFib, is one of the cardiovascular conditions most frequently discussed in relation to obstructive sleep apnea.

AF is an abnormal heart rhythm arising from disorganized electrical activity in the atria.

OSA and AF commonly coexist.

That does not mean every patient with AF has sleep apnea, or that OSA is the sole cause of AF.

However, several physiologic effects of obstructive sleep apnea may provide plausible links between the two conditions.

How Might OSA Contribute to Atrial Fibrillation?

Potential mechanisms include:

• Intermittent hypoxemia
• Sympathetic nervous-system activation
• Repeated arousals
• Blood-pressure surges
• Large intrathoracic-pressure changes
• Autonomic instability
• Inflammatory and oxidative pathways
• Structural and electrical atrial remodeling

During an obstructive apnea, the patient may make increasingly strong inspiratory efforts against a closed or narrowed upper airway.

This can produce substantial negative intrathoracic pressure.

At the same time:

oxygen may fall → sympathetic activity rises → blood pressure and heart rate change → the airway reopens

Repeated over months or years, these physiologic stresses may contribute to an environment in which atrial arrhythmias are more likely in susceptible individuals.

Does Sleep Apnea Cause AFib?

It is more accurate to say that OSA is associated with AF and may contribute to its development or persistence.

AF itself is multifactorial.

Other important contributors include:

• Age
• Hypertension
• Obesity
• Structural heart disease
• Heart failure
• Valvular disease
• Alcohol
• Thyroid disease
• Genetics
• Other cardiovascular conditions

Therefore:

AF + OSA does not prove that OSA caused the arrhythmia.

But identifying and appropriately treating clinically significant OSA may be an important component of comprehensive AF management.

Should Someone With Atrial Fibrillation Be Evaluated for Sleep Apnea?

OSA is common in people with AF, and evaluation may be appropriate when clinical features suggest sleep-disordered breathing.

Possible clues include:

• Loud habitual snoring
• Witnessed apneas
• Nocturnal gasping
• Obesity
• Resistant hypertension
• Daytime sleepiness
• Nonrestorative sleep
• Other recognized OSA risk factors

The decision to test should be individualized.

Symptoms alone cannot reliably diagnose OSA.

Does CPAP Prevent Atrial Fibrillation From Coming Back?

This requires careful wording.

Observational studies have suggested that OSA treatment may be associated with better AF-related outcomes in some populations, including after rhythm-control procedures.

However, observational associations do not establish that PAP guarantees prevention of recurrent AF.

The evidence is more complicated than:

OSA → CPAP → AF can never return.

Patients with AF should continue appropriate cardiology management even when OSA is successfully treated.

Can You Stop AF Medication After Starting CPAP?

Not simply because PAP therapy has begun.

Anticoagulation, rate-control medication, rhythm-control medication, and other AF treatments address specific cardiovascular risks.

Those decisions should be based on the patient’s cardiac condition and appropriate clinical assessment.

Treating OSA does not automatically replace established AF therapy.

What About Other Heart-Rhythm Problems?

OSA has also been studied in relation to other arrhythmias.

Potential contributors include:

• Hypoxemia
• Autonomic fluctuations
• Repeated arousals
• Intrathoracic-pressure changes
• Underlying cardiac disease

But an abnormal heart rhythm during the night should not automatically be attributed to sleep apnea.

The specific arrhythmia and clinical circumstances require appropriate evaluation.

Can Sleep Apnea Cause a Slow Heart Rate During Sleep?

Heart rate can fluctuate during obstructive respiratory events.

Some patients may demonstrate relative slowing during portions of an apnea followed by acceleration around arousal and airway reopening.

However, clinically significant bradyarrhythmias have multiple possible causes.

A low nighttime heart rate alone does not diagnose OSA.

Likewise, documented significant bradycardia or conduction abnormalities deserve appropriate cardiac evaluation rather than being assumed to be caused by sleep apnea.

Can Sleep Apnea Cause Palpitations?

Patients with OSA may report palpitations, but palpitations are nonspecific.

Possible causes include:

• Premature beats
• Atrial fibrillation
• Other arrhythmias
• Anxiety
• Caffeine
• Medications
• Thyroid disease
• Other cardiovascular conditions

Persistent or concerning palpitations should be evaluated appropriately.

Sleep Apnea and Coronary Artery Disease

OSA is also associated with coronary artery disease and other manifestations of atherosclerotic cardiovascular disease.

Potential pathways include:

• Hypertension
• Sympathetic activation
• Oxidative stress
• Endothelial dysfunction
• Inflammation
• Metabolic dysfunction

But shared risk factors are again important.

For example:

obesity → increased OSA risk

and:

obesity → increased cardiovascular risk

can occur simultaneously.

Researchers therefore attempt to separate the independent contribution of OSA from the effects of associated conditions.

Does Untreated OSA Mean You Will Have a Heart Attack?

No.

Risk is not destiny.

Many people with OSA will never have a myocardial infarction.

And many heart attacks occur in people without OSA.

The appropriate message is:

OSA may contribute to cardiovascular risk, but an individual’s actual risk depends on the complete cardiovascular profile.

That includes factors such as:

• Age
• Blood pressure
• Cholesterol
• Diabetes
• Smoking
• Family history
• Kidney disease
• Obesity
• Physical activity
• Existing vascular disease

Fear-based claims such as:

“If you don’t use CPAP, you will have a heart attack”

are not medically appropriate.

Does CPAP Guarantee Protection From a Heart Attack?

No.

PAP treats the obstructive breathing disorder while it is being effectively used.

It does not eliminate every mechanism of cardiovascular disease.

A patient using PAP may still require treatment for:

• Hypertension
• Dyslipidemia
• Diabetes
• Smoking
• Obesity
• Coronary artery disease
• Other cardiovascular conditions

OSA treatment should therefore be incorporated into broader cardiovascular risk management.

Can OSA Affect the Heart Even Without Coronary Artery Disease?

Potentially.

OSA can influence cardiovascular physiology through:

• Blood-pressure changes
• Sympathetic activation
• Cardiac loading conditions
• Oxygen disturbances
• Sleep fragmentation

These mechanisms are not limited to coronary atherosclerosis.

That is one reason OSA is also studied in relation to arrhythmias and heart failure.

Sleep Apnea and Stroke

Stroke, or cerebrovascular accident (CVA), is another major condition associated with OSA.

Research has found a high prevalence of sleep-disordered breathing among patients with cerebrovascular disease.

But the relationship can be complex.

OSA may be present before a stroke.

Sleep-disordered breathing may also be recognized during evaluation after a stroke.

Therefore, the relationship should not be reduced to:

“Sleep apnea causes stroke.”

How Might OSA Contribute to Stroke Risk?

Potential pathways include:

• Hypertension
• Recurrent blood-pressure surges
• Intermittent hypoxemia
• Sympathetic activation
• Endothelial dysfunction
• Metabolic dysfunction
• Atrial fibrillation
• Other cardiovascular mechanisms

Some of these factors interact.

For example:

OSA may contribute to hypertension

while:

hypertension itself is a major stroke risk factor.

Similarly:

OSA is associated with AF

while:

AF can substantially increase embolic stroke risk.

The network of risk is therefore more complex than one direct pathway.

Does Untreated Sleep Apnea Mean You Will Have a Stroke?

No.

OSA is a risk factor or associated condition—not a prediction that an individual will definitely experience a stroke.

Stroke risk is influenced by many factors, including:

• Hypertension
• Atrial fibrillation
• Diabetes
• Smoking
• Dyslipidemia
• Age
• Vascular disease
• Prior stroke or TIA
• Other medical conditions

OSA should be considered within that broader risk profile.

Can Sleep Apnea Occur After a Stroke?

Yes.

Sleep-disordered breathing is common among stroke patients.

In some cases, OSA likely existed before the stroke but had never been diagnosed.

Neurologic injury can also influence breathing and sleep.

The specific pattern may include obstructive or central abnormalities depending on the individual circumstances.

Should Stroke Patients Be Evaluated for Sleep Apnea?

OSA is common in stroke populations, and sleep-disordered breathing assessment may be appropriate depending on the patient’s clinical circumstances.

However, testing decisions depend on:

• Neurologic status
• Symptoms
• Medical stability
• Ability to participate in testing
• Clinical suspicion
• Type of sleep-disordered breathing being considered

Screening should not be confused with diagnosis.

Can Treating OSA Prevent Another Stroke?

Again, this requires nuance.

Treating OSA effectively addresses obstructive respiratory events during sleep.

But secondary stroke prevention also requires appropriate management of established vascular risk factors such as:

• Blood pressure
• Atrial fibrillation
• Diabetes
• Cholesterol
• Smoking
• Antiplatelet or anticoagulant therapy when indicated
• Other individualized factors

PAP should not be presented as a substitute for evidence-based stroke-prevention strategies.

What Is a TIA?

A transient ischemic attack (TIA) is a neurologic event caused by transient cerebral ischemia without the persistent infarction characteristic of a completed ischemic stroke.

Symptoms suggesting stroke or TIA require urgent medical evaluation.

These can include sudden:

• Facial weakness
• Arm or leg weakness
• Numbness
• Speech difficulty
• Vision changes
• Severe imbalance
• Other focal neurologic symptoms

Do not wait to see whether treating sleep apnea makes acute neurologic symptoms disappear.

Sleep Apnea and Heart Failure

OSA is common among patients with heart failure.

The interaction can be clinically important because sleep-disordered breathing can influence:

• Sympathetic activity
• Oxygenation
• Blood pressure
• Cardiac loading
• Sleep quality

But heart failure also introduces an important complication:

Not all sleep-disordered breathing in heart failure is obstructive.

What Is the Difference Between OSA and Central Sleep Apnea in Heart Failure?

Obstructive Sleep Apnea

The upper airway obstructs while respiratory effort continues.

Central Sleep Apnea

Breathing effort decreases or temporarily stops because of instability in respiratory control.

Some patients with heart failure may demonstrate central sleep apnea with a periodic breathing pattern, including Cheyne-Stokes respiration.

These disorders should not be treated as interchangeable.

For a detailed comparison of these breathing disorders, see Central vs. Obstructive Sleep Apnea: What’s the Difference?

Why Does the Difference Matter?

Because the appropriate PAP strategy depends on the type of sleep-disordered breathing and the patient’s cardiac condition.

A treatment appropriate for straightforward OSA is not automatically appropriate for every central breathing disorder.

Therefore:

Heart failure + abnormal nighttime breathing requires accurate characterization of the breathing disorder.

Can CPAP Be Used in Someone With Heart Failure and OSA?

Yes, CPAP may be used to treat obstructive sleep apnea in appropriately selected patients with heart failure.

But the complete treatment plan should consider:

• Cardiac function
• Type of sleep-disordered breathing
• Symptoms
• Oxygenation
• PAP tolerance
• Other medical conditions

Heart-failure therapy itself remains essential.

Does Treating OSA Cure Heart Failure?

No.

Heart failure is a complex cardiovascular syndrome requiring appropriate medical treatment.

Treating coexisting OSA may address one relevant physiologic stressor, but it does not replace:

• Guideline-directed heart-failure therapy
• Volume management
• Blood-pressure management
• Rhythm management
• Other indicated cardiac treatment

Can Untreated OSA Worsen Nighttime Symptoms in Heart Failure?

Potentially.

Sleep-disordered breathing may contribute to:

• Sleep fragmentation
• Nocturnal oxygen disturbances
• Sympathetic activation
• Poor sleep quality

However, nighttime shortness of breath in a patient with heart failure should not automatically be attributed to OSA.

Other important causes include:

• Pulmonary congestion
• Orthopnea
• Paroxysmal nocturnal dyspnea
• Arrhythmia
• Pulmonary disease
• Other cardiopulmonary conditions

New or worsening nighttime breathlessness deserves appropriate clinical evaluation.

When Should Cardiovascular Symptoms Receive Urgent Attention?

Do not assume acute cardiovascular symptoms are simply caused by sleep apnea.

Urgent evaluation may be appropriate for symptoms such as:

• New or severe chest pain
• Severe shortness of breath
• Fainting
• New sustained palpitations with concerning symptoms
• Sudden neurologic deficit
• New weakness or speech difficulty
• Other potentially serious cardiovascular or neurologic symptoms

OSA is a chronic risk factor.

It should never become an explanation that delays evaluation of an acute emergency.

The Cardiovascular Bottom Line So Far

Untreated OSA is associated with important cardiovascular and cerebrovascular conditions, including:

• Hypertension
• Resistant hypertension
• Atrial fibrillation
• Coronary disease
• Stroke
• Heart failure

The biologic links are plausible and multifactorial.

But three statements should remain separate:

1. OSA is associated with cardiovascular disease.

2. OSA may contribute biologically to cardiovascular risk.

3. Treating OSA does not guarantee elimination of every cardiovascular event.

That distinction allows patients to understand why OSA matters without exaggerating what PAP therapy can promise.

Can Untreated Sleep Apnea Cause Excessive Daytime Sleepiness?

Yes.

Excessive daytime sleepiness is one of the best-known symptoms of obstructive sleep apnea, although not everyone with OSA reports being sleepy.

Repeated obstruction during sleep can produce:

• Frequent arousals
• Sleep fragmentation
• Reduced restorative sleep
• Intermittent oxygen disturbances
• Repeated sympathetic activation

A person may spend seven or eight hours in bed but still awaken feeling unrefreshed.

Possible daytime consequences include:

• Sleepiness
• Fatigue
• Difficulty concentrating
• Reduced vigilance
• Slower reaction time
• Memory complaints
• Irritability
• Reduced work performance
• Unintentional dozing

The severity varies considerably among individuals.

Is Sleepiness the Same as Fatigue?

No.

These terms are often used interchangeably, but clinically they describe different experiences.

Sleepiness

A tendency or increased propensity to fall asleep.

Examples include:

• Dozing while reading
• Falling asleep while watching television
• Nodding off during meetings
• Struggling to stay awake as a passenger
• Becoming sleepy while driving

Fatigue

A sense of:

• Low energy
• Exhaustion
• Reduced stamina
• Lack of motivation
• Physical or mental weariness

A patient can have:

sleepiness without prominent fatigue

or:

fatigue without an increased tendency to fall asleep.

This distinction matters when evaluating whether OSA explains a patient’s daytime symptoms.

Does Everyone With Severe OSA Feel Sleepy?

No.

Some patients with substantial OSA report surprisingly little subjective sleepiness.

Others with less severe OSA may report marked daytime impairment.

The relationship between AHI and subjective sleepiness is imperfect.

Factors that may influence daytime symptoms include:

• Sleep duration
• Degree of sleep fragmentation
• Hypoxemia
• Age
• Medications
• Work schedule
• Circadian factors
• Other sleep disorders
• Individual susceptibility

Therefore:

“I don’t feel sleepy” does not prove that OSA is absent or physiologically unimportant.

Can People Underestimate Their Own Sleepiness?

Yes.

This is particularly important for driving and occupational safety.

A person may adapt gradually to chronic sleepiness and begin to consider impaired alertness normal.

They may say:

“I’m not sleepy. I just get tired on long drives.”

or:

“I only nod off when the road is boring.”

Those statements may still indicate impaired vigilance.

Subjective perception of alertness is not always a perfect measure of actual performance.

What Is a Microsleep?

A microsleep is a very brief episode of sleep or sleep-like loss of alertness that may occur unintentionally.

During a microsleep, a person may temporarily fail to process information from the environment.

Even a few seconds can be dangerous during:

• Driving
• Operating machinery
• Working at heights
• Monitoring safety-critical systems

At highway speed, a vehicle can travel a substantial distance during only a few seconds of lost attention.

Do You Always Know When You Have a Microsleep?

No.

A person may recognize:

• Head nodding
• Heavy eyelids
• Missing part of a conversation
• Drifting within a traffic lane

But some brief lapses may not be consciously recognized.

That is one reason severe sleepiness should not be judged solely by whether the individual remembers falling asleep.

Can Untreated OSA Affect Attention and Reaction Time?

Yes.

Sleep fragmentation and excessive sleepiness may impair:

• Sustained attention
• Vigilance
• Reaction time
• Decision-making
• Working memory
• Executive function

These effects are particularly important in tasks requiring prolonged concentration.

Examples include:

• Driving
• Piloting
• Operating heavy equipment
• Monitoring industrial systems
• Clinical work
• Other safety-sensitive occupations

Can OSA Affect Memory?

It can.

Patients may report:

• Forgetfulness
• Difficulty concentrating
• Reduced mental clarity
• Trouble sustaining attention
• “Brain fog”

But these symptoms are nonspecific.

Other causes include:

• Insufficient sleep
• Depression
• Anxiety
• Medications
• Neurologic disease
• Metabolic disorders
• Other sleep conditions

Cognitive symptoms should therefore not automatically be attributed to OSA.

Can Untreated Sleep Apnea Affect Mood?

OSA and sleep fragmentation may be associated with:

• Irritability
• Mood disturbance
• Reduced quality of life
• Depressive symptoms in some patients

But depression and anxiety are independent clinical conditions and may coexist with OSA.

Treating OSA does not automatically resolve every psychiatric symptom.

Can Untreated Sleep Apnea Increase Motor-Vehicle Accident Risk?

Yes.

Untreated OSA—particularly when associated with excessive daytime sleepiness—is associated with increased motor-vehicle crash risk.

Potential contributors include:

sleepiness → impaired vigilance → slower reaction time → attention lapses → microsleeps

Driving is especially vulnerable because it requires continuous attention over long periods.

How Much Does OSA Increase Crash Risk?

Studies have found an increased crash risk among drivers with untreated OSA, but the exact magnitude varies among populations and study designs.

Risk is not determined by AHI alone.

Important contributors include:

• Degree of sleepiness
• Sleep duration
• OSA severity
• Treatment status
• Shift work
• Driving duration
• Time of day
• Sedating medications
• Alcohol
• Other sleep disorders

Therefore, it is not appropriate to assign every person with the same AHI the same driving risk.

Does Mild Sleep Apnea Make Driving Unsafe?

Not automatically.

Driving risk depends on more than the diagnostic category of:

mild

moderate

or:

severe OSA.

A patient with mild OSA but profound sleepiness may present a different safety concern from a patient with more severe OSA who is effectively treated and alert.

Relevant factors include:

• Excessive sleepiness
• History of crashes or near misses
• Treatment effectiveness
• PAP adherence
• Sleep duration
• Medications
• Occupation
• Other medical conditions

For more about how mild OSA should be interpreted in clinical context, see Mild Sleep Apnea: Does It Need Treatment?

What Are Warning Signs of Dangerous Driving Sleepiness?

Warning signs include:

• Difficulty keeping the eyes open
• Frequent yawning
• Head nodding
• Drifting from the lane
• Hitting rumble strips
• Missing exits
• Difficulty remembering the last several miles
• Repeatedly adjusting the window, radio, or temperature to stay awake
• Needing frequent stimulation to remain alert
• Near-miss accidents
• Brief unintended sleep episodes

These signs should be taken seriously.

Is Opening the Window Enough to Prevent Drowsy Driving?

No.

Common strategies such as:

• Opening a window
• Turning up the radio
• Chewing gum
• Slapping the face
• Increasing air conditioning

do not reliably reverse physiologic sleepiness.

They may temporarily increase stimulation without correcting the underlying need for sleep.

Does Coffee Make It Safe to Drive With Severe Sleepiness?

Caffeine can temporarily improve alertness in some circumstances.

But it should not be used to justify continued driving when a person is struggling to stay awake.

Severe sleepiness can overwhelm compensatory strategies.

The safest response to significant drowsiness is to stop driving and address the sleepiness, rather than attempting to push through it.

What Should You Do if You Are Falling Asleep While Driving?

If you are struggling to remain awake, do not continue driving simply because you are close to your destination.

Move to a safe location and stop driving.

Persistent or recurrent driving sleepiness deserves evaluation.

If untreated OSA is present, effective treatment becomes particularly important.

Can CPAP Reduce Driving Risk?

Effective PAP treatment can improve excessive daytime sleepiness and driving-related performance in many patients with OSA.

Observational evidence also supports reduced crash risk after effective treatment.

But treatment must actually be used.

A PAP machine sitting beside the bed does not treat OSA.

For more about why PAP should cover the entire sleep period rather than simply reach an administrative threshold, see CPAP Compliance: How Many Hours a Night Should You Use CPAP?

Does Four Hours of CPAP Automatically Make Driving Safe?

No.

This is another reason administrative compliance and clinical effectiveness should not be confused.

For more about interpreting whether PAP is actually controlling OSA, see CPAP Not Working? Signs Your Sleep Apnea Treatment Needs Reassessment.

Consider:

PAP use: 4 hours

followed by:

3 hours of untreated sleep

The patient may meet a particular usage threshold but still have incomplete treatment exposure.

Driving safety should consider:

• Effective OSA treatment
• Sleepiness
• Total sleep duration
• Treatment adherence
• Residual respiratory events
• Medications
• Other relevant factors

Can You Still Be Sleepy Even When CPAP Works?

Yes.

Persistent sleepiness despite apparently effective PAP may result from:

• Insufficient sleep
• Insomnia
• Circadian misalignment
• Medications
• Other sleep disorders
• Medical conditions
• Residual excessive daytime sleepiness

Therefore:

PAP-treated OSA + persistent driving sleepiness

still deserves attention.

For a systematic evaluation of persistent symptoms despite PAP, see Why Am I Still Tired After Using CPAP?

Untreated Sleep Apnea and Workplace Accidents

The safety implications of untreated OSA extend beyond motor vehicles.

Sleepiness and impaired vigilance can become hazardous in occupations involving:

• Heavy machinery
• Commercial vehicles
• Construction equipment
• Work at heights
• Industrial processes
• Electrical systems
• Emergency response
• Transportation
• Other safety-sensitive duties

The degree of risk depends on the individual’s actual impairment and job responsibilities.

Why Are Safety-Sensitive Jobs Different?

A brief attention lapse while reading at home may have little consequence.

The same lapse while:

• Driving a truck
• Operating a crane
• Controlling industrial equipment
• Working near hazardous machinery

may have serious consequences.

Therefore, the functional impact of sleepiness must be considered in context.

Can Shift Work Make OSA-Related Sleepiness Worse?

Yes.

OSA and insufficient or circadian-disrupted sleep can coexist.

For example:

OSA + night-shift work + chronically short sleep

may produce greater impairment than any one factor alone.

Treating OSA does not eliminate the physiologic consequences of chronic sleep deprivation.

Can You Have Treated OSA but Still Be Unsafe Because You Do Not Sleep Enough?

Yes.

Suppose PAP data show:

Excellent usage
Low residual AHI
Minimal leak

but the patient sleeps only:

4–5 hours per night.

PAP may be effectively treating the OSA while chronic sleep restriction still produces dangerous sleepiness.

This distinction is essential in occupational assessment.

Does OSA Automatically Disqualify Someone From Driving or Working?

No.

A diagnosis of OSA does not automatically mean that a person is permanently unable to drive or perform safety-sensitive work.

The relevant issues may include:

• Severity
• Symptoms
• Treatment effectiveness
• Adherence
• Daytime alertness
• Applicable regulations
• Individual occupational requirements

Regulatory standards can differ by jurisdiction and occupation.

What About Commercial Drivers?

Commercial driving introduces specific medical and regulatory considerations.

Requirements can change and may depend on:

• Jurisdiction
• Licensing category
• Medical examiner standards
• Employer policies
• Treatment documentation

This article is not intended to substitute for current DOT/FMCSA or other applicable regulatory guidance.

The general safety principle remains:

Clinically significant sleepiness and inadequately treated OSA deserve attention in anyone operating a vehicle, especially professionally.

Should Someone With Untreated OSA Drive if They Are Not Sleepy?

This cannot be answered solely from the diagnosis.

OSA severity, treatment status, objective and subjective impairment, sleep duration, medications, crash history, occupation, and applicable regulations may all matter.

However, anyone experiencing significant sleepiness while driving should not rely on the absence of a formal restriction as proof that continuing to drive is safe.

What About a Previous Crash or Near Miss?

A history of:

• Falling asleep at the wheel
• A sleepiness-related crash
• Recurrent lane drifting
• Near misses
• Microsleep while driving

raises the importance of prompt evaluation and effective management.

The history may be more clinically informative than simply asking:

“Are you sleepy?”

Why Can Accident Risk Improve Before Every Other Symptom Does?

PAP may improve alertness relatively quickly in some sleepy patients once obstructive sleep-disordered breathing is effectively treated.

But response varies.

The patient should not assume:

“I used CPAP for one night, so my driving risk is now completely normal.”

Assess actual alertness and treatment effectiveness over time.

Can Alcohol or Sedating Medication Compound the Risk?

Yes.

Sleepiness from OSA can interact with:

• Alcohol
• Sedative medications
• Opioids
• Some antihistamines
• Sleep medications
• Other centrally acting drugs

The combined effect may be greater than either factor alone.

Patients should understand the effects of prescribed and over-the-counter medications on alertness and driving.

Why Is This a Public-Safety Issue?

Untreated OSA may affect not only the patient.

A sleepy driver or machinery operator can place:

• Passengers
• Other motorists
• Coworkers
• Pedestrians
• The public

at risk.

That is why excessive sleepiness deserves direct discussion rather than being treated merely as an inconvenience.

The Safety Bottom Line

When evaluating untreated sleep apnea risks, ask more than:

“What is the AHI?”

Also ask:

• Is the patient excessively sleepy?
• Are microsleeps occurring?
• Has driving become difficult?
• Have there been near misses?
• Is the patient operating heavy equipment?
• Is shift work present?
• Is total sleep duration adequate?
• Are sedating medications or alcohol contributing?
• Is OSA actually being treated throughout sleep?

For safety-sensitive activities, functional impairment matters.

Why Does Obstructive Sleep Apnea Matter Before Surgery?

Obstructive sleep apnea can affect perioperative planning because several features of surgery and recovery may increase vulnerability to upper-airway obstruction or respiratory depression.

These can include:

• Sedative medications
• General anesthesia
• Opioids
• Residual anesthetic effects
• Supine positioning
• Postoperative sleep
• Reduced upper-airway muscle tone
• Coexisting obesity
• Cardiopulmonary disease

OSA does not automatically mean that surgery is unsafe or should be canceled.

The important principle is:

Known or suspected OSA should be recognized so the surgical, anesthesia, and postoperative-care teams can incorporate it into individualized planning.

What Does “Perioperative” Mean?

Perioperative refers to the period surrounding surgery.

It includes:

Preoperative

Evaluation and preparation before the procedure.

Intraoperative

The period during the procedure and anesthesia.

Postoperative

Recovery after the procedure, including the period when sedatives, anesthetics, analgesics, and the physiologic effects of surgery may still influence breathing.

OSA may be relevant during all three phases.

Why Can Anesthesia Matter in OSA?

Normal sleep already reduces upper-airway muscle activity.

Anesthetic and sedating medications can further alter:

• Upper-airway muscle tone
• Respiratory drive
• Arousal responses
• Ventilation
• Protective reflexes

A patient with an airway that is prone to collapse during natural sleep may therefore deserve additional consideration when medications alter airway and respiratory physiology.

Does OSA Mean You Cannot Have General Anesthesia?

No.

Many patients with OSA undergo procedures requiring general anesthesia.

The diagnosis is information that helps the anesthesia team plan appropriately.

Relevant considerations may include:

• OSA severity
• PAP treatment
• Airway anatomy
• Obesity
• Cardiopulmonary disease
• Type and duration of surgery
• Anesthetic technique
• Postoperative analgesia
• Expected opioid exposure
• Recovery environment

The appropriate plan is individualized.

Can OSA Make Airway Management More Difficult?

OSA can coexist with anatomic characteristics associated with more challenging airway management.

But:

OSA diagnosis ≠ guaranteed difficult intubation.

Anesthesiologists assess the airway using multiple clinical features.

These may include:

• Mouth opening
• Jaw anatomy
• Neck mobility
• Dentition
• Oropharyngeal anatomy
• Neck characteristics
• Prior airway-management history
• Other relevant findings

OSA should be part of the history, not treated as a substitute for an airway examination.

Why Should You Tell the Anesthesiologist You Have Sleep Apnea?

Because the anesthesia team may use that information when considering:

• Airway strategy
• Sedative medication
• Anesthetic technique
• Opioid use
• Postoperative monitoring
• Recovery location
• PAP use
• Other respiratory precautions

Do not assume that OSA is automatically obvious from the medical record.

Tell the team directly.

What Information About Your OSA Should You Provide?

Useful information may include:

• Whether OSA has been formally diagnosed
• Whether it is mild, moderate, or severe if known
• PAP treatment
• CPAP, APAP, or bilevel mode
• Whether PAP is used regularly
• Whether you still have significant symptoms
• Any oxygen or ventilation concerns
• Prior anesthesia problems
• Relevant sleep-study or PAP information when requested

You do not need to memorize every number from your sleep study to tell the team that OSA is present.

Should You Bring Your CPAP Machine to Surgery?

Sometimes patients are instructed to bring their PAP equipment for postoperative use.

Requirements vary according to:

• Hospital or surgical facility
• Type of surgery
• Expected admission
• OSA severity
• Local policy
• Anesthesia plan

Follow the facility’s specific instructions.

If you are uncertain before surgery, ask whether you should bring:

• PAP device
• Mask
• Tubing
• Power supply
• Other required components

Does Bringing CPAP Mean You Will Definitely Use It Immediately After Surgery?

Not necessarily.

Postoperative PAP decisions depend on:

• Type of procedure
• Surgical site
• Airway considerations
• Patient alertness
• Respiratory status
• Nausea/vomiting risk
• Monitoring environment
• Treating-team instructions

Do not independently apply PAP immediately after every procedure without considering the surgical and anesthesia plan.

Why Are Opioids Important in Patients With OSA?

Opioids can depress respiration and alter arousal responses.

In susceptible patients, they may worsen sleep-related respiratory vulnerability.

Potential concerns include:

• Reduced respiratory drive
• Greater sleepiness
• Upper-airway obstruction
• Hypoventilation
• Oxygen desaturation
• Reduced ability to respond normally to respiratory abnormalities

This does not mean a patient with OSA can never receive an opioid.

It means opioid requirements and respiratory risk should be considered carefully.

Does OSA Make You “Allergic” to Opioids?

No.

OSA is not an opioid allergy.

The concern is respiratory sensitivity and vulnerability, not an allergic reaction.

That distinction matters.

Should People With OSA Refuse All Pain Medication?

No.

Poorly controlled pain has its own consequences.

Modern perioperative care may use multimodal analgesia, combining different approaches to reduce reliance on any one medication class when appropriate.

The specific plan depends on:

• Procedure
• Patient
• Comorbidities
• Kidney/liver function
• Bleeding considerations
• Medication allergies
• Other factors

Pain management should be individualized.

What About Sedatives and Sleeping Pills After Surgery?

Sedating medications may affect:

• Alertness
• Upper-airway tone
• Respiratory drive
• Coordination with opioids or anesthetic effects

Medication combinations can be particularly important.

Patients should not add extra sedatives, sleep aids, alcohol, or other centrally acting substances after surgery without considering the treating team’s instructions.

Can OSA Cause Problems in the Recovery Room?

OSA may contribute to postoperative respiratory vulnerability.

Potential issues can include:

• Recurrent upper-airway obstruction
• Snoring
• Apnea
• Oxygen desaturation
• Hypoventilation in selected patients
• Excessive sedation
• Difficulty maintaining airway patency

The actual risk varies substantially among patients and procedures.

Does Every Patient With OSA Need Intensive Care After Surgery?

No.

Postoperative monitoring should be individualized.

Relevant factors may include:

• OSA severity
• Procedure
• Anesthetic technique
• Opioid requirement
• Comorbidities
• Respiratory events in recovery
• Oxygenation
• PAP requirements
• Ability to maintain airway patency

Some patients undergo ambulatory procedures successfully.

Others may require more prolonged observation or monitoring.

Why Can the Postoperative Night Be Important?

Residual effects from:

• Anesthesia
• Opioids
• Sedatives
• Surgery
• Sleep disruption

can interact with OSA.

Sleep architecture may also change during postoperative recovery.

The risk profile can therefore evolve after the patient leaves the operating room.

This is one reason perioperative planning extends beyond the procedure itself.

Can Supplemental Oxygen Fix Postoperative OSA?

Supplemental oxygen can improve oxygen saturation in appropriate patients.

But oxygen and PAP do not perform the same function.

Supplemental Oxygen

Increases inspired oxygen concentration.

PAP

Helps maintain upper-airway patency and treats obstructive respiratory events.

A patient can potentially have improved oxygen saturation while still experiencing:

• Upper-airway obstruction
• Hypoventilation
• Other respiratory abnormalities

Therefore, oxygen saturation should be interpreted in clinical context.

For more about oxygen saturation, desaturation, and why oxygen alone does not define OSA severity, see Sleep Apnea and Oxygen Levels: How Low Is Too Low?

Can Oxygen Mask Respiratory Problems?

In selected circumstances, supplemental oxygen can make oxygen saturation appear reassuring while ventilation or obstructive respiratory abnormalities remain important.

This does not mean oxygen should be avoided when clinically indicated.

It means:

Oxygen saturation is only one component of respiratory assessment.

What About Obesity and Surgery in Someone With OSA?

Obesity may add additional perioperative considerations.

These can include:

• Airway anatomy
• Respiratory mechanics
• Reduced functional residual capacity
• Hypoventilation risk in selected patients
• Cardiometabolic disease
• Venous thromboembolic risk
• Technical surgical considerations

But obesity and OSA should not be treated as identical conditions.

A patient can have:

obesity without OSA

or:

OSA without obesity.

This will connect naturally to our planned Article #26 on OSA, obesity, and weight reduction.

What Is Obesity Hypoventilation Syndrome?

Obesity hypoventilation syndrome is a distinct disorder involving obesity and awake alveolar hypoventilation after other causes are appropriately considered.

It is not simply:

“severe sleep apnea in someone who is overweight.”

Patients may have coexisting OSA, but ventilation concerns can alter clinical management.

This distinction may be particularly important perioperatively.

Does a Low CPAP AHI Mean There Is No Surgical Risk?

No.

A low residual PAP AHI may indicate effective control of machine-detected respiratory events during PAP use.

But perioperative risk depends on much more than a home PAP number.

Relevant factors include:

• Whether PAP is actually used
• Surgery type
• Anesthesia
• Opioids
• Airway
• Cardiopulmonary disease
• Obesity
• Oxygenation/ventilation
• Postoperative monitoring

Do not use one PAP metric as a surgical-clearance test.

What if OSA Is Suspected but Has Never Been Diagnosed?

This is common.

Some surgical patients have clinical features suggesting OSA but have never undergone formal testing.

Possible clues include:

• Loud habitual snoring
• Witnessed apnea
• Nocturnal gasping
• Hypertension
• Obesity
• Daytime sleepiness
• Other airway or clinical risk factors

Perioperative screening tools may help identify patients at increased probability of OSA.

But:

Screening is not the same as diagnosis. For more about diagnostic testing options, see Home Sleep Apnea Test vs. Lab Sleep Study: Which One Do You Need?

What Is STOP-Bang?

STOP-Bang is a commonly used OSA screening questionnaire.

The acronym incorporates clinical features involving:

S — Snoring
T — Tiredness
O — Observed apnea
P — Pressure/high blood pressure

and additional factors:

B — BMI
A — Age
N — Neck circumference
G — Gender/sex-related risk component used by the instrument

The score estimates the likelihood or risk category for OSA.

It does not directly measure AHI.

Does a High STOP-Bang Score Prove You Have OSA?

No.

STOP-Bang is a screening tool, not a diagnostic sleep study.

A high-risk result may indicate that OSA deserves consideration.

It does not tell you:

• Exact AHI
• Sleep stage
• Oxygen burden
• Event type
• Required PAP pressure

Similarly, a screening score should not be used to independently prescribe PAP.

Should Every Patient Be Sent for a Sleep Study Before Surgery?

Not necessarily.

The decision depends on:

• Clinical suspicion
• Urgency of surgery
• Type of procedure
• Comorbidities
• Expected perioperative risk
• Whether testing would change management

Some procedures can proceed with appropriate risk mitigation when OSA is suspected.

Other circumstances may justify additional evaluation before elective surgery.

The decision is individualized.

Does Newly Diagnosed OSA Automatically Delay Surgery?

No.

A new OSA diagnosis does not automatically mean surgery must be canceled or postponed.

The decision depends on the overall perioperative situation.

Important questions include:

• How urgent is the surgery?
• How severe is the suspected or confirmed OSA?
• Are significant cardiopulmonary problems present?
• Is hypoventilation suspected?
• What type of anesthesia is planned?
• What postoperative monitoring is available?

What About “Pulmonary Clearance” for Surgery?

The term clearance can be misleading.

A pulmonary or sleep clinician generally does not make surgery risk-free.

A more useful objective is:

perioperative pulmonary/sleep risk assessment and optimization.

That may involve:

• Identifying relevant respiratory disease
• Assessing OSA treatment
• Reviewing oxygenation or ventilation concerns
• Recommending risk-reduction strategies
• Communicating relevant findings to the surgical/anesthesia team

The ultimate decision to proceed involves the patient and treating surgical/anesthesia teams within the broader clinical context.

Should PAP Be Started Right Before Surgery if OSA Is Newly Diagnosed?

Sometimes treatment may be initiated before an elective procedure, but the appropriate approach depends on:

• OSA severity
• Symptoms
• Time available
• Comorbidities
• Surgical urgency
• Treatment tolerance

One or two nights of PAP should not be portrayed as magically eliminating all perioperative risk.

The broader objective is effective treatment and appropriate perioperative planning.

What if You Already Use CPAP Successfully?

Tell the surgical and anesthesia teams.

Useful information includes:

• Regular PAP use
• Current mode
• Mask/interface
• Whether treatment is well tolerated
• Any significant residual problems

Follow facility instructions regarding perioperative PAP use.

What if You Rarely Use Your Prescribed CPAP?

Tell the team that too.

Do not report:

“I use CPAP”

if the reality is:

“I own CPAP but rarely wear it.”

The distinction can matter because prescribed therapy and actual treatment exposure are not the same.

For more about recorded PAP usage versus actual treatment throughout sleep, see CPAP Compliance: How Many Hours a Night Should You Use CPAP?

Should You Hide OSA Because You Are Afraid Surgery Will Be Canceled?

No.

Withholding an important respiratory diagnosis prevents the anesthesia and surgical teams from incorporating it into the plan.

OSA is common.

The objective is not to punish the patient for having sleep apnea.

It is to plan safely.

Can Untreated OSA Increase Perioperative Complication Risk?

OSA has been associated with increased perioperative respiratory and other complications in selected populations.

The magnitude of risk varies according to:

• OSA severity
• Obesity
• Procedure
• Anesthesia
• Opioid exposure
• Comorbidities
• Monitoring
• Treatment status

Therefore:

OSA is a perioperative risk factor—not a universal prediction of complications.

What Should Patients With OSA Ask Before Surgery?

Useful questions include:

1. Does my surgical/anesthesia team know I have OSA?
2. Should I bring my PAP machine and mask?
3. When should PAP be used after surgery?
4. Will opioids or sedatives be required?
5. What type of postoperative monitoring is planned?
6. Is this expected to be outpatient or inpatient surgery?
7. Are there special instructions for my PAP equipment?
8. Are there additional concerns because of my heart or lung disease?

The exact answers depend on the procedure and facility.

The Perioperative Bottom Line

OSA does not automatically prohibit surgery.

But known or suspected OSA can matter because:

anesthesia + sedation + opioids + airway vulnerability + postoperative sleep

may increase respiratory risk in susceptible patients.

The safest approach is:

recognize OSA → communicate it → incorporate it into anesthesia and postoperative planning → use PAP when appropriate according to the clinical plan → monitor according to individualized risk.

Can Untreated Sleep Apnea Affect Metabolic Health?

Yes.

Obstructive sleep apnea is associated with several metabolic abnormalities, including:

• Insulin resistance
• Type 2 diabetes
• Obesity
• Metabolic syndrome
• Abnormal glucose regulation

However, these relationships are complex.

OSA frequently coexists with obesity, and obesity itself is strongly associated with insulin resistance and type 2 diabetes.

Therefore, it would be overly simplistic to say:

“Sleep apnea causes diabetes.”

A more accurate framework is:

OSA and metabolic disease frequently coexist, share important risk factors, and may influence one another through several physiologic pathways.

How Might OSA Affect Glucose Metabolism?

Potential mechanisms include:

• Intermittent hypoxemia
• Sympathetic nervous-system activation
• Sleep fragmentation
• Altered stress-hormone signaling
• Inflammatory pathways
• Oxidative stress

Chronic insufficient sleep and disrupted sleep architecture may also influence metabolic regulation.

But the metabolic consequences of OSA cannot be separated completely from factors such as:

• Body weight
• Diet
• Physical activity
• Genetics
• Medications
• Sleep duration
• Other medical conditions

Is Sleep Apnea Common in Type 2 Diabetes?

Yes.

OSA is common among people with type 2 diabetes, particularly when obesity or other OSA risk factors are present.

Likewise, abnormal glucose metabolism is common among patients with OSA.

This overlap means that clinicians may consider the possibility of sleep apnea when a patient with diabetes also has features such as:

• Loud habitual snoring
• Witnessed apnea
• Nocturnal gasping
• Excessive sleepiness
• Resistant hypertension
• Obesity
• Other clinical risk factors

But diabetes alone does not diagnose OSA.

Does Treating OSA Cure Diabetes?

No.

PAP treats sleep-disordered breathing.

It does not replace established diabetes treatment.

A patient may still require:

• Nutrition management
• Physical activity
• Weight management
• Glucose-lowering medication
• Cardiovascular risk reduction
• Other individualized diabetes care

OSA treatment should be considered part of overall health management rather than a substitute for metabolic treatment.

Does CPAP Improve Blood Sugar?

Research examining PAP and glucose metabolism has produced variable results.

Some patients or populations may demonstrate metabolic improvement, particularly when PAP is used effectively and for substantial portions of sleep.

But the evidence does not support telling patients:

“Use CPAP and your diabetes will disappear.”

Metabolic outcomes depend on many factors beyond OSA treatment.

Sleep Apnea and Obesity

Obesity is one of the most important risk factors for obstructive sleep apnea.

Increased adipose tissue can influence upper-airway anatomy and respiratory physiology through several mechanisms.

Potential contributors include:

• Increased soft tissue around the upper airway
• Changes in pharyngeal anatomy
• Reduced lung volumes
• Altered upper-airway mechanics
• Increased collapsibility in susceptible individuals

But:

OSA is not simply a disease of obesity.

People who are not obese can have clinically significant obstructive sleep apnea.

Can Thin People Have Severe Sleep Apnea?

Yes.

OSA can occur because of factors such as:

• Craniofacial anatomy
• Jaw structure
• Upper-airway dimensions
• Tonsillar tissue
• Neuromuscular control of the airway
• Age
• Genetics
• Other anatomic and physiologic factors

Therefore:

normal body weight does not exclude OSA.

Likewise:

Obesity does not prove that someone has OSA.

Diagnosis still requires appropriate clinical assessment and testing.

Can Weight Gain Make OSA Worse?

It can.

Weight gain may increase upper-airway collapsibility and worsen OSA in susceptible individuals.

But the relationship is not perfectly linear.

A particular amount of weight gain may substantially affect one patient and have a smaller effect in another.

Can Weight Loss Improve OSA?

Yes.

Weight reduction can improve OSA severity in many patients with overweight or obesity.

The magnitude of improvement varies.

Some patients experience:

• Lower AHI
• Reduced oxygen disturbance
• Improved symptoms
• Lower PAP pressure requirements in some circumstances

But weight loss does not guarantee that OSA disappears.

This is important enough to state clearly:

Weight loss can improve OSA without necessarily curing it.

Our next major article will examine this in detail, including lifestyle intervention, anti-obesity medications, GLP-1–based therapies, and bariatric/metabolic surgery.

Should You Stop CPAP After Losing Weight?

Not simply because the scale shows substantial weight loss.

A patient can lose a large amount of weight and still have clinically important OSA.

If OSA may have substantially changed, reassessment can determine whether treatment is still needed or should be modified.

Do not simply stop PAP and assume the disease has resolved.

Can Weight Regain Cause OSA to Return or Worsen?

Potentially.

If weight reduction improves OSA and substantial weight is later regained, upper-airway obstruction may worsen again.

That is one reason OSA and weight management should be viewed longitudinally rather than as a one-time intervention.

Can Untreated OSA Cause Nocturia?

OSA can contribute to nocturia in some patients.

Nocturia means waking during the sleep period to urinate.

Possible contributors in OSA include physiologic changes associated with:

• Repeated obstructive events
• Negative intrathoracic pressure
• Cardiac stretch
• Natriuretic peptide signaling
• Sleep fragmentation

Effective OSA treatment may reduce nocturia in some patients.

But nocturia has many other causes.

What Else Causes Nocturia?

Possible contributors include:

• Evening fluid intake
• Diuretic medications
• Diabetes
• Prostate disease
• Bladder disorders
• Heart failure
• Kidney disease
• Sleep fragmentation from other causes
• Other medical conditions

Therefore:

Nighttime urination does not automatically mean sleep apnea.

And persistent nocturia despite effective PAP does not automatically mean PAP is failing.

Can Sleep Apnea Cause Morning Headaches?

Morning headaches can occur in patients with OSA.

Potential contributors may include:

• Sleep fragmentation
• Nocturnal respiratory abnormalities
• Carbon-dioxide changes in selected circumstances
• Other sleep-related factors

But morning headache is nonspecific.

Other causes include:

• Migraine
• Tension headache
• Bruxism
• Medication effects
• Hypertension
• Other medical conditions

A persistent or changing headache pattern deserves appropriate evaluation.

Can Untreated OSA Affect Sexual Function?

OSA has been associated with sexual dysfunction in some populations.

Possible contributing factors include:

• Endothelial dysfunction
• Cardiovascular disease
• Metabolic disease
• Hormonal factors
• Sleep fragmentation
• Fatigue
• Mood disturbance
• Obesity
• Medication effects

For example, erectile dysfunction may coexist with OSA in men.

But sexual dysfunction is multifactorial.

It should not automatically be attributed to sleep apnea.

Does CPAP Cure Erectile Dysfunction?

Not reliably.

Some patients may experience improvement after effective OSA treatment, particularly when sleepiness, sleep quality, or other OSA-related factors contribute.

But erectile dysfunction can result from:

• Vascular disease
• Diabetes
• Medication effects
• Hormonal disorders
• Neurologic disease
• Psychological factors
• Other causes

Persistent symptoms deserve appropriate evaluation.

Can Untreated OSA Affect Quality of Life?

Yes.

OSA can affect daily functioning through:

• Sleepiness
• Fatigue
• Poor concentration
• Mood changes
• Morning headaches
• Reduced work performance
• Relationship effects
• Driving limitations
• Treatment-related concerns

For some patients, these functional consequences are more noticeable than the cardiovascular associations.

Can OSA Affect Relationships?

Potentially.

Examples include:

• Loud snoring disturbing a bed partner
• Witnessed apneas causing concern
• Separate sleeping arrangements
• Irritability related to poor sleep
• Sexual dysfunction
• Daytime fatigue affecting shared activities

Treating sleep-disordered breathing may improve some of these problems, but relationship difficulties can have many causes.

Does Mild Sleep Apnea Carry the Same Risk as Severe Sleep Apnea?

Not necessarily.

In general, greater OSA severity can be associated with greater physiologic burden.

But individual risk cannot be predicted from AHI category alone.

Consider two patients.

Patient A

AHI: 12 events/hour

but also:

• Marked daytime sleepiness
• Resistant hypertension
• Significant oxygen desaturation
• Previous drowsy-driving near miss

Patient B

AHI: 32 events/hour

but:

• Minimal subjective sleepiness
• Less pronounced desaturation
• No known cardiovascular disease

The second patient has the higher AHI.

But the complete clinical risk assessment is more complicated than simply comparing:

12 versus 32.

For a broader discussion of when mild OSA may warrant treatment, see Mild Sleep Apnea: Does It Need Treatment?

What Else Determines OSA Risk Besides AHI?

Potentially important factors include:

• Oxygen-desaturation burden
• Event duration
• Sleep fragmentation
• Daytime sleepiness
• Hypertension
• Cardiovascular disease
• Stroke history
• Obesity
• Diabetes
• Age
• Sleep stage
• Sleeping position
• Total sleep duration
• Individual susceptibility

This is why treatment decisions should not rely solely on whether the AHI falls into a particular numerical category.

For a detailed explanation of AHI categories and their limitations, see AHI Explained: What Your Apnea-Hypopnea Index Means.

Is Severe Oxygen Desaturation More Important Than AHI?

It can provide important additional information, but neither measure should automatically replace the other.

For example:

AHI tells us event frequency.

Oxygen data provide information about the degree and pattern of desaturation.

Neither alone captures every physiologic consequence of OSA.

For a deeper discussion of oxygen patterns in OSA, see Sleep Apnea and Oxygen Levels: How Low Is Too Low?

Does REM-Related OSA Matter?

Yes.

Some patients have substantially worse obstruction during REM sleep.

REM sleep tends to become more prominent during later portions of the sleep period.

Therefore, someone with REM-predominant OSA may have clinically important disease even if the whole-night AHI appears less dramatic than expected.

For more about why OSA can become substantially worse during dream sleep, see REM-Related Sleep Apnea: Why OSA Can Be Worse During Dream Sleep.

Does Positional OSA Matter?

Yes.

Some patients experience much more severe OSA while sleeping on the back.

The overall AHI may therefore depend heavily on how much time was spent:

supine

versus:

nonsupine.

For more about body position and OSA severity, see Positional Sleep Apnea: Why OSA May Be Worse on Your Back.

If You Don’t Feel Sleepy, Is Untreated OSA Harmless?

No.

Absence of subjective sleepiness does not establish absence of:

• Hypertension
• Oxygen disturbance
• Cardiovascular stress
• Sleep fragmentation
• Other physiologic consequences

However, the opposite overstatement should also be avoided:

Every asymptomatic patient with OSA does not have identical cardiovascular risk.

OSA is heterogeneous.

Why Can Someone With Severe OSA Feel Fine?

Possible explanations include:

• Individual differences in susceptibility to sleep fragmentation
• Gradual adaptation to chronic symptoms
• Underrecognition of impairment
• Different OSA phenotypes
• Differences in sleep duration
• Other biologic factors

Some patients only recognize how impaired they were after effective treatment improves their daytime function.

Others remain minimally symptomatic even after careful assessment.

Should Asymptomatic OSA Be Ignored?

Not simply because the patient says:

“I feel fine.”

Treatment decisions should consider:

• OSA severity
• Oxygenation
• Cardiovascular comorbidities
• Symptoms
• Safety-sensitive activities
• Patient preferences
• Other clinical factors

The absence of sleepiness is one piece of information—not the entire decision.

Does Snoring Alone Carry the Same Risk as OSA?

No.

Snoring and obstructive sleep apnea are related but not identical.

A person can snore without meeting diagnostic criteria for OSA.

Likewise, some patients with OSA may not report dramatic snoring.

The health-risk discussion in this article concerns obstructive sleep apnea, not simple snoring alone.

Can You Determine Untreated OSA Risk From a Smartwatch?

Not reliably.

Consumer wearables may provide useful information about:

• Sleep patterns
• Heart rate
• Estimated oxygenation on some devices
• Other physiologic trends

But they do not independently establish the complete diagnosis, severity, or cardiovascular risk of OSA.

A smartwatch alert should be interpreted as information that may warrant appropriate evaluation—not as a complete sleep study.

Can You Determine Risk From One Night of Sleep Testing?

A sleep study provides important diagnostic information, but OSA can vary from night to night.

Factors include:

• Sleeping position
• REM sleep
• Alcohol
• Nasal congestion
• Medication
• Total sleep time

Clinical interpretation therefore combines the test result with symptoms, medical history, and other risk factors.

The Risk Principle

The most useful way to think about untreated sleep apnea risks is:

OSA severity + physiologic burden + symptoms + comorbidities + safety exposure + individual susceptibility

rather than:

AHI alone.

That framework helps explain why two people with apparently similar sleep-study numbers may require different clinical conversations.

Untreated Sleep Apnea Risks: Putting the Evidence Into Perspective

The risks associated with untreated OSA should be taken seriously without assuming that every person with sleep apnea will experience the same outcome.

Risk or Concern	Why OSA May Matter	What Else Affects Risk	What Not to Assume
High blood pressure	Sympathetic activation, intermittent hypoxemia, arousals and nighttime BP surges may contribute	Weight, genetics, diet, kidney disease, medications, age	OSA is the only cause of hypertension
Resistant hypertension	OSA is common in difficult-to-control hypertension	Medication adherence, secondary causes, obesity, kidney disease	CPAP replaces antihypertensive treatment
Atrial fibrillation	Autonomic changes, pressure swings, hypoxemia and atrial stress may contribute	Age, hypertension, obesity, structural heart disease, alcohol	CPAP guarantees AF will not recur
Coronary/cardiovascular disease	OSA may contribute through sympathetic, vascular, inflammatory and metabolic pathways	Smoking, cholesterol, diabetes, BP, genetics, obesity	Every heart attack in someone with OSA was caused by OSA
Stroke/CVA	OSA is associated with cerebrovascular risk and may interact with hypertension and AF	BP, AF, diabetes, smoking, vascular disease, age	Treating OSA eliminates all stroke risk
Heart failure	OSA can add respiratory, autonomic and hemodynamic stress	Cardiac function, coronary disease, hypertension, rhythm, kidney disease	Treating OSA cures heart failure
Motor-vehicle crash	Sleepiness, impaired vigilance and microsleeps can increase risk	Sleep duration, medications, alcohol, shift work, driving exposure	AHI alone determines whether someone is safe to drive
Workplace accident	Reduced vigilance can be hazardous in safety-sensitive work	Occupation, sleep duration, shifts, medication, actual sleepiness	Every worker with OSA is occupationally impaired
Surgery/anesthesia	Airway vulnerability, sedatives, opioids and postoperative sleep may increase respiratory risk	Procedure, anesthesia, obesity, comorbidities, monitoring	OSA automatically prohibits surgery
Metabolic dysfunction	Sleep fragmentation and intermittent hypoxemia may contribute to metabolic stress	Weight, diet, activity, genetics, medications	Treating OSA alone cures diabetes
Poor quality of life	Sleepiness, fatigue and fragmented sleep may impair daily function	Other sleep disorders, mood, medical illness, sleep duration	Every symptom is caused by OSA

Untreated OSA should be viewed as one component of an individual’s overall cardiovascular, neurologic, metabolic, perioperative, and safety risk—not as a guarantee that a particular complication will occur.

Does Treating Sleep Apnea Reduce These Risks?

Treating clinically significant OSA has important benefits.

Depending on the patient and treatment, these may include:

• Fewer obstructive respiratory events
• Improved oxygenation during treated sleep
• Reduced snoring
• Improved excessive daytime sleepiness
• Better daytime function
• Improved quality of life
• Modest average reductions in blood pressure in some populations
• Reduced drowsy-driving risk when sleepiness improves
• Better control of sleep-disordered breathing during PAP-treated sleep

But treatment should not be presented as a guarantee against every cardiovascular or neurologic event.

Why Doesn’t CPAP Eliminate Every Cardiovascular Risk?

Because cardiovascular disease has many causes.

Even someone with perfectly treated OSA may still have:

• Hypertension
• Diabetes
• Dyslipidemia
• Obesity
• Smoking exposure
• Atrial fibrillation
• Kidney disease
• Coronary artery disease
• Genetic risk
• Age-related vascular risk

PAP treats the sleep-related obstructive breathing disorder.

It does not replace comprehensive cardiovascular prevention.

Why Have Some Cardiovascular CPAP Trials Been Less Dramatic Than Expected?

This is an important question.

Observational studies have demonstrated substantial associations between OSA and cardiovascular disease.

However, randomized trials evaluating PAP for prevention of major cardiovascular events have not uniformly demonstrated large reductions in events such as myocardial infarction or stroke in all studied populations.

Possible explanations and limitations include:

• Patient selection
• Exclusion of very sleepy patients from some trials
• Established cardiovascular disease
• Variable nightly PAP use
• Partial-night treatment
• Different OSA phenotypes
• Differences in physiologic burden
• Duration of follow-up
• Other competing cardiovascular risks

This does not mean:

“CPAP doesn’t matter.”

It means the evidence should be interpreted according to the outcome being discussed.

What Outcomes Does PAP Clearly Help?

PAP is highly effective at controlling obstructive respiratory events in appropriately treated OSA.

It can also improve excessive daytime sleepiness and quality of life in many symptomatic patients.

Other benefits may include improvements in:

• Snoring
• Sleep-related breathing
• Nocturnal symptoms
• Blood pressure in selected patients

The magnitude of benefit varies.

Does More PAP Use Matter?

Yes.

PAP works while it is being used.

A patient who sleeps eight hours but uses PAP for only four hours may leave a substantial portion of sleep untreated.

That matters when considering both symptoms and physiologic exposure.

For more about why treatment exposure should cover the sleep period, see CPAP Compliance: How Many Hours a Night Should You Use CPAP?

Does a Low AHI on CPAP Mean All Risk Is Gone?

No.

A low residual AHI is reassuring when treatment is being used appropriately.

But it does not establish that:

• PAP covers the entire sleep period
• Blood pressure is normal
• Diabetes is controlled
• AF has resolved
• Cardiovascular disease is absent
• The patient gets enough sleep
• Every symptom is caused by OSA
• Every cardiovascular risk factor has been corrected

For detailed interpretation of residual PAP AHI, see CPAP AHI: What Should Your AHI Be on Treatment?

What if PAP Is Used All Night but OSA Still Is Not Controlled?

Then treatment effectiveness deserves reassessment.

Reviews may include:

• Residual AHI
• Event type
• Leak
• Pressure
• PAP mode
• Symptoms
• Oxygenation or ventilation when relevant

For a structured treatment reassessment framework, see CPAP Not Working? Signs Your Sleep Apnea Treatment Needs Reassessment.

What About Treatments Other Than CPAP?

PAP is not the only possible treatment for OSA.

Depending on the patient, alternatives or adjunctive approaches may include:

• Weight reduction
• Positional therapy
• Oral appliance therapy
• Upper-airway surgery
• Hypoglossal nerve stimulation
• Other individualized treatments

The appropriate treatment depends on:

• OSA severity
• Anatomy
• Symptoms
• Comorbidities
• Treatment tolerance
• Patient preference
• Other clinical factors

The goal is effective treatment, not simply ownership of a CPAP machine. For a detailed explanation of one established non-PAP treatment—including how mandibular advancement devices work, who may be a candidate, effectiveness, side effects, titration, and follow-up testing—see Oral Appliance Therapy for Sleep Apnea: How It Works, Who Qualifies, and Does It Work?

Another option for appropriately selected patients is hypoglossal nerve stimulation. For a detailed explanation of how Inspire works, who may qualify, DISE and airway-collapse patterns, effectiveness, implantation, programming, risks, and long-term follow-up, see Inspire for Sleep Apnea: How Hypoglossal Nerve Stimulation Works, Who Qualifies, and Does It Work?

Upper-airway surgery may also be appropriate for selected patients when an identifiable anatomic problem contributes to obstruction. Because sleep apnea surgery includes very different procedures—with different goals, success rates, risks, and recovery—see Sleep Apnea Surgery: Types, Who Qualifies, Success Rates, Risks, and Alternatives for a detailed guide to tonsillectomy, UPPP and other palatal procedures, tongue-base surgery, maxillomandibular advancement, nasal surgery, multilevel surgery, and postoperative assessment.

Can Weight Loss Reduce Untreated Sleep Apnea Risk?

Weight reduction can improve OSA severity in many patients with overweight or obesity.

It may also improve important cardiovascular and metabolic risk factors independent of its effect on OSA.

But weight reduction does not guarantee elimination of sleep apnea.

Sleep Apnea and Obesity: Can Weight Loss, GLP-1 Drugs, or Bariatric Surgery Improve OSA?

Should You Wait to Treat OSA Until You Lose Weight?

Not automatically.

Meaningful weight reduction may take months or longer.

If clinically significant OSA is already present, treatment decisions should consider the current disease rather than assuming future weight loss will eliminate it.

Weight management and OSA therapy can occur together.

Can Lifestyle Changes Help Overall Risk Even if OSA Persists?

Yes.

Depending on the individual, cardiovascular-risk reduction may include:

• Weight management
• Regular physical activity
• Smoking cessation
• Appropriate nutrition
• Blood-pressure treatment
• Diabetes management
• Lipid management
• Limiting problematic alcohol use
• Adequate sleep duration
• OSA treatment

This is a broader strategy than focusing on AHI alone.

A Practical Risk-Reduction Framework

When OSA is diagnosed, consider five questions.

1. How Significant Is the Sleep-Disordered Breathing?

Review:

• AHI or REI
• Oxygenation
• Event pattern
• Sleep stage
• Sleeping position
• Symptoms
• Relevant physiologic findings

2. What Comorbidities Are Present?

Examples include:

• Hypertension
• Resistant hypertension
• Atrial fibrillation
• Coronary disease
• Heart failure
• Stroke/TIA
• Diabetes
• Obesity
• Pulmonary disease

These conditions can change the clinical importance of OSA.

3. Is Daytime Function Impaired?

Ask about:

• Sleepiness
• Microsleeps
• Driving difficulty
• Near misses
• Cognitive symptoms
• Occupational impairment

Safety may require more immediate attention than long-term statistical risk.

4. Is Treatment Actually Effective?

For PAP users, review:

• Usage
• Residual events
• Leak
• Pressure
• Mask tolerance
• Whether PAP remains on throughout sleep

A prescribed treatment that is rarely used is not equivalent to effective therapy.

5. What Other Risk Factors Need Treatment?

Do not allow OSA to distract from:

• Blood pressure
• Cholesterol
• Diabetes
• Smoking
• Obesity
• AF
• Physical inactivity
• Other established cardiovascular risks

Comprehensive treatment matters.

When Should Untreated OSA Be Addressed Promptly?

Prompt clinical attention becomes particularly important when OSA is associated with:

• Severe excessive daytime sleepiness
• Falling asleep while driving
• Motor-vehicle crash or near miss
• Safety-sensitive occupation
• Significant oxygen desaturation
• Resistant hypertension
• Important cardiovascular disease
• Atrial fibrillation
• Heart failure
• Prior stroke or TIA
• Planned surgery with relevant perioperative concerns
• Significant PAP intolerance preventing treatment

The urgency depends on the complete clinical situation.

When Is It an Emergency?

OSA itself is generally a chronic disorder.

But symptoms occurring in a person with OSA may represent an unrelated or associated emergency.

Seek urgent/emergency evaluation for symptoms such as:

• New severe chest pain or pressure
• Severe unexplained shortness of breath
• Fainting
• Sudden facial droop
• Sudden arm or leg weakness
• Sudden numbness
• New speech difficulty
• Acute severe neurologic symptoms
• Other potentially life-threatening symptoms

Do not wait for a sleep appointment or PAP adjustment when symptoms suggest an acute cardiovascular or neurologic emergency.

Untreated Sleep Apnea Risks: 10 Questions to Ask

1. How Severe Is My OSA?

Ask about more than the label mild, moderate, or severe.

2. How Low Does My Oxygen Go?

Consider both the degree and pattern of desaturation.

3. Am I Excessively Sleepy?

Driving and occupational safety may depend on this.

4. Do I Have High Blood Pressure?

OSA can be relevant, particularly when hypertension is difficult to control.

5. Do I Have Atrial Fibrillation or Other Cardiovascular Disease?

These conditions may affect the clinical importance of OSA.

6. Have I Ever Had a Stroke or TIA?

Cerebrovascular history belongs in the overall risk assessment.

7. Is My OSA Treatment Actually Working?

Prescription alone does not establish effective treatment.

8. Am I Using Treatment Throughout Sleep?

Partial-night PAP can leave later sleep untreated.

9. Do I Have Surgery Planned?

Make sure the surgical and anesthesia teams know about diagnosed or suspected OSA.

10. What Other Risk Factors Should I Address?

OSA treatment should be part of a broader health strategy.

Five Mistakes to Avoid

Mistake 1: Assuming Everyone With OSA Will Have a Heart Attack or Stroke

OSA increases or is associated with risk; it does not determine an individual’s destiny.

Mistake 2: Assuming No Daytime Sleepiness Means OSA Is Harmless

Important physiologic consequences may occur without obvious subjective sleepiness.

Mistake 3: Assuming CPAP Eliminates Every Cardiovascular Risk

Treat hypertension, diabetes, cholesterol, smoking, obesity, AF, and other risks appropriately.

Mistake 4: Ignoring Driving Sleepiness Because the AHI Is “Only Mild”

Functional impairment and safety history matter.

Mistake 5: Hiding OSA Before Surgery

The surgical and anesthesia teams need accurate information to plan appropriately.

A Better Way to Think About Untreated Sleep Apnea Risks

Instead of asking:

“Will sleep apnea cause a heart attack or stroke?”

ask:

1. What Physiologic Burden Is My OSA Producing?

Consider events, oxygenation, sleep fragmentation, and symptoms.

2. What Other Health Conditions Do I Have?

OSA may interact with cardiovascular and metabolic disease.

3. Is OSA Affecting My Immediate Safety?

Driving sleepiness and occupational impairment may require prompt attention.

4. Is My Treatment Effective and Sustainable?

Treatment only helps when it actually controls the disorder and is used appropriately.

5. What Other Modifiable Risks Can I Address?

OSA is one part of overall cardiovascular and metabolic health.

The Bottom Line

Untreated obstructive sleep apnea is more than a snoring disorder.

Repeated upper-airway obstruction can expose the body to:

• Intermittent hypoxemia
• Recurrent arousals
• Sympathetic activation
• Blood-pressure surges
• Intrathoracic-pressure changes
• Sleep fragmentation
• Other physiologic stress

OSA is associated with important health and safety concerns, including:

• Hypertension
• Resistant hypertension
• Atrial fibrillation
• Cardiovascular disease
• Stroke
• Heart failure
• Metabolic dysfunction
• Excessive daytime sleepiness
• Motor-vehicle crashes
• Occupational accidents
• Perioperative respiratory risk

But risk should be communicated accurately.

OSA is not the only cause of cardiovascular disease.

Not every patient with OSA will experience these complications.

Treating OSA does not guarantee that every cardiovascular event will be prevented.

At the same time:

absence of symptoms does not prove that clinically important OSA is harmless.

The most useful approach is to consider:

OSA severity + physiologic burden + symptoms + cardiovascular/metabolic comorbidities + safety exposure + treatment effectiveness + individual susceptibility.

Then address both:

the sleep apnea

and:

the patient’s other modifiable health risks.

The goal is not to frighten patients into treatment.

It is to understand where untreated OSA fits into the broader picture of cardiovascular health, neurologic health, metabolic health, surgical safety, daytime function, and accident prevention.

References & Further Reading

1. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e56–e67.
   https://doi.org/10.1161/CIR.0000000000000988
2. Patil SP, Ayappa IA, Caples SM, et al. Treatment of Adult Obstructive Sleep Apnea With Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. Journal of Clinical Sleep Medicine. 2019;15(2):335–343.
   https://doi.org/10.5664/jcsm.7640
3. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The Sleep Heart Health Study. Circulation. 2010;122(4):352–360.
   https://doi.org/10.1161/CIRCULATIONAHA.109.901801
4. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: The Sleep Heart Health Study. American Journal of Respiratory and Critical Care Medicine. 2010;182(2):269–277.
   https://doi.org/10.1164/rccm.200911-1746OC
5. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. New England Journal of Medicine. 2000;342(19):1378–1384.
   https://doi.org/10.1056/NEJM200005113421901
6. Tregear S, Reston J, Schoelles K, Phillips B. Obstructive sleep apnea and risk of motor vehicle crash: systematic review and meta-analysis. Journal of Clinical Sleep Medicine. 2009;5(6):573–581.
   https://pmc.ncbi.nlm.nih.gov/articles/PMC2792976/
7. Tregear S, Reston J, Schoelles K, Phillips B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea: systematic review and meta-analysis. Sleep. 2010;33(10):1373–1380.
   https://doi.org/10.1093/sleep/33.10.1373
8. Chung F, Memtsoudis SG, Ramachandran SK, et al. Society of Anesthesia and Sleep Medicine Guidelines on Preoperative Screening and Assessment of Adult Patients With Obstructive Sleep Apnea. Anesthesia & Analgesia. 2016;123(2):452–473.
   https://doi.org/10.1213/ANE.0000000000001416
9. Memtsoudis SG, Cozowicz C, Nagappa M, et al. Society of Anesthesia and Sleep Medicine Guideline on Intraoperative Management of Adult Patients With Obstructive Sleep Apnea. Anesthesia & Analgesia. 2018;127(4):967–987.
   https://doi.org/10.1213/ANE.0000000000002822
10. American Academy of Sleep Medicine. Sleep Education — Obstructive Sleep Apnea.
    https://sleepeducation.org/sleep-disorders/obstructive-sleep-apnea/

Medical Author & Reviewer
Kwaku Osafo-Mensah, MD
Pulmonary Medicine | Sleep Medicine
Diplomate, American Board of Sleep Medicine (ABSM)
More than 20 years of experience in sleep medicine

Medically reviewed: September 2026
About the medical reviewer · Editorial Policy

Medical Disclaimer: This article is provided for general educational purposes and is not a substitute for individualized medical evaluation, diagnosis, treatment, perioperative assessment, or professional advice about driving or occupational safety. The health risks associated with obstructive sleep apnea vary according to OSA severity, physiologic burden, symptoms, cardiovascular and metabolic conditions, treatment effectiveness, medications, occupation, and individual circumstances. OSA is associated with hypertension, cardiovascular and cerebrovascular disease, excessive sleepiness, accident risk, and perioperative respiratory concerns, but these relationships do not mean that OSA is the sole cause of every associated condition or that treatment guarantees prevention of cardiovascular events. Do not stop cardiovascular medications, change prescribed PAP treatment, ignore significant driving sleepiness, or alter a surgical or anesthesia plan solely on the basis of generalized internet information. New chest pain, severe shortness of breath, fainting, sudden weakness, facial droop, speech difficulty, or other symptoms suggesting an acute cardiovascular or neurologic emergency require prompt medical evaluation.